Amgen (AMGN) Q4 earnings and revenue beat estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Amgen (AMGN) Tops Q4 EPS by 12c, Offers Guidance
February 6, 2024 4:03 PM ESTAmgen (NASDAQ: AMGN) reported Q4 EPS of $4.71, $0.12 better than the analyst estimate of $4.59. Revenue for the quarter came in at $8.2 billion versus the consensus estimate of $8.12 billion.
GUIDANCE:
Amgen sees FY2024 EPS of $18.90-$20.30, versus the consensus of $19.83. Amgen sees... More
